80 results
Page 3 of 4
S-3
s8le3u93j yj21uq
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
an120 1lxzb
19 Jan 22
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
4:09pm
8-K
EX-99.1
zwz93gq
5 Jan 22
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
2:22pm
8-K
EX-2.1
bml3u4xaewg
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
oxykg 0jdt
24 Sep 21
Annual report
7:31am
10-K
nbrq6
24 Sep 21
Annual report
7:31am
424B3
b55oi7ez7 r7
22 Jul 21
Prospectus supplement
10:27am
8-K
EX-99.1
vgys 2tzpbb
29 Jun 21
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
3:12pm
424B3
50018jqb
16 Mar 21
Prospectus supplement
12:00am
424B4
g449 6zcgunduh
13 Nov 20
Prospectus supplement with pricing info
8:52pm